Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases
- PMID: 17097377
- DOI: 10.1016/j.jaad.2006.05.068
Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases
Abstract
Three patients suffering from classic dermatomyositis (juvenile and adult-onset) with prominent recalcitrant skin manifestations are described. All patients demonstrated good control of muscle symptoms on immunosuppressive medications, but their cutaneous disease persisted despite treatment with at least 4 different systemic treatments and topical agents. They were given rituximab, a monoclonal anti-CD20 antibody, achieving a response with minimal side effects. We document our experience with this medication for the cutaneous lesions of dermatomyositis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
